A qualitative study of increasing β-blocker use after myocardial infarction -: Why do some hospitals succeed?

被引:226
|
作者
Bradley, EH
Holmboe, ES
Mattera, JA
Roumanis, SA
Radford, MJ
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[3] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
来源
关键词
D O I
10.1001/jama.285.20.2604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.
引用
收藏
页码:2604 / 2611
页数:8
相关论文
共 50 条
  • [41] A qualitative study: Perceptions of the psychosocial consequences and access to support after an acute myocardial infarction
    Junehag, Lena
    Asplund, Kenneth
    Svedlund, Marianne
    INTENSIVE AND CRITICAL CARE NURSING, 2014, 30 (01) : 22 - 30
  • [42] Safety Culture and Mortality after Acute Myocardial Infarction: A Study of Medicare Beneficiaries at 171 Hospitals
    Shahian, David M.
    Liu, Xiu
    Rossi, Laura P.
    Mort, Elizabeth A.
    Normand, Sharon-Lise T.
    HEALTH SERVICES RESEARCH, 2018, 53 (02) : 608 - 631
  • [43] EFFECTS AND USE OF SOME SLOW CHANNEL CALCIUM INHIBITORS AFTER MYOCARDIAL-INFARCTION
    NINORET, P
    BERNASCONI, P
    COEUR, 1986, 17 (06): : 377 - 381
  • [44] 'Just like a normal pain', what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals
    Berman, Nikita
    Jones, Melvyn Mark
    De Coster, Daan A.
    BMJ OPEN, 2017, 7 (09):
  • [45] Mortality reduction associated with beta-blocker therapy in patients after a myocardial infarction who do not undergo cardiac catheterization
    Barron, HV
    Viskin, S
    Lundstrom, RJ
    Wong, CC
    Swain, BE
    Truman, AF
    Selby, JV
    CIRCULATION, 1996, 94 (08) : 1538 - 1538
  • [46] Sexual rehabilitation after myocardial infarction and coronary bypass surgery: Why do we not perform our job?
    Djurovic, Aleksandar
    Maric, Dragan
    Brdareski, Zorica
    Konstantinovic, Ljubica
    Rafajlovski, Saso
    Obradovic, Slobodan
    Ilic, Radoje
    Mijailovic, Zdravko
    VOJNOSANITETSKI PREGLED, 2010, 67 (07) : 579 - 587
  • [47] Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario (vol 161, pg 1403, 1999)
    Rochon, PA
    Anderson, GM
    Tu, JV
    Clark, JP
    Gurwitz, JH
    Szalai, JP
    Lau, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (01) : 19 - 19
  • [49] Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study
    Rasmussen, Daniel B.
    Bodtger, Uffe
    Lamberts, Morten
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Lange, Peter
    Jensen, Magnus T.
    THORAX, 2020, 75 (11) : 928 - 933
  • [50] Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study
    Ratzki-Leewing, Alexandria
    Black, Jason E.
    Ryan, Bridget L.
    Zou, Guangyong
    Harris, Stewart B.
    DIABETES, 2021, 70